FDA Approves Omaveloxolone As First Treatment for Friedreich Ataxia
The FDA has approved omaveloxolone (Skyclarys), an agent developed by Reata Pharmaceuticals for the treatment of Friedreich ataxia in adults and adolescents aged 16 years and older, making it the…







